A simple and rapid method was validated to determine furosemide in whole blood. The experimental work was performed so that all validation parameters are considered simultaneously in a one-day assay protocol. A solid-phase extraction procedure using BondElut| Certify columns was used to extract this compound from blood samples, while ketoprofen was used as an internal standard. The extracts were analyzed by gas chromatography-electron ionization-mass spectrometry after on-column derivatization with trimethylanilinium hydroxide (0.2M in methanol). Calibration curves were prepared daily, between 0.10 and 5.00 pg/mL, and the correlation coefficients were above 0.9910. The calculated limits of detection and quantitation were 0.010 and 0.045 pg/mL, respectively. Control samples at low, medium, and high concentrations (0.30, 0.75, and 3.00 pg/mL) of furosemide of an independent source were measured in the same day. Precision and trueness, calculated in terms of relative standard deviation (%), were less than 15% for all concentration levels. The relative recoveries calculated for the three levels of the control samples were 104%, 89%, and 91%, respectively. In general, a sensitive, specific, and reliable procedure has been developed for the determination of furosemide in whole blood samples and was found suitable for the application in postmortem forensic toxicology routine analysis.
Introduction
Furosemide ( Figure 1 , 4-chloro-N-furfuryl-5-sulfamoylanthranilic acid) is an anthranilic acid derivative with strong diuretic potential (1, 2) . It exerts its action on the luminal side of the thick ascending limb of the Henle's loop by inhibiting active chloride transport (reabsorption) with sodium passively following (3) (4) (5) (6) . This action of furosemide has a vasodilator renal effect, resulting both in a decrease of the vascular resistance and in an increase in the renal blood * Author to whom correspondence should be addressed. E-maih claudiamargalho@iol.pt.
flow. Therefore, the excretion of salts and water is enhanced (6, 7) . This potent loop diuretic used in adults and children is employed in the pharmacotherapy of various diseases, namely congestive heart failure, hypertension, renal diseases, cirrhosis, and some types of edema (8) . After oral administration, furosemide is rapidly absorbed by the gastrointestinal tract with a bioavailability of about 65%. Up to 90% of an intravenous dose is excreted in urine, mainly as unchanged drug, and up to 14% is excreted as a glucuronide metabolite (8, 9) . Its plasma half-life is about 1 to 3 h, and increases in subjects with renal failure, congestive heart failure, liver disease, and in neonates (4,5). This substance extensively binds to plasma protein (about 90%) (10) . Serum levels in the range of 2-10 IJg/mL and 25-30 lJg/mL are reported to be respectively therapeutic and toxic concentrations (11) .
Although furosemide is included in the list of prohibited doping substances indicated by the World Anti-Doping Agency (WADA) (12) , it is widely used in sports, mainly in competitions classified by weight or to avoid detection of other drugs (13, 14) .
Several methods for the detection of furosemide in urine, plasma, and serum using solid-phase extraction (SPE) and liquid chromatography or liquid-liquid extraction followed by gas chromatography (GC) have been described (6, 8, 10, (15) (16) (17) (18) (19) (20) . To the best of our knowledge, the determination of this substance in whole blood has not been reported. This paper describes a reliable and reproducible methodology for furosemide quantitation in whole blood samples using a GC-electron ionization-mass spectrometry (EI-MS) procedure after SPE and oncolumn derivatization with trimethylanilinium hydroxide (TMAH) (21) , which was rapid and sensitive enough for postmortem forensic toxicology studies. 
Instrumentation and chromatographic conditions
Chromatography was conducted on a Hewlett-Packard (Waldbronn, Germany) 6890 series GC, equipped with a model HP 5973 mass selective detector (Waldbronn, Germany). A capillary column (12 m x 0.25-ram i.d., 0.25-pro film thickness) packed with 5% phenylmethylsiloxane (Ultra 2) supplied by J&W Scientific (Folsom, CA), was used. The carrier gas was helium at a constant flow rate of 1 mL/min. Chromatographic conditions were as follows: initial oven temperature was 160~ for I rain, increased by 20~ to 270~ and held for 8.5 rain. The temperatures of the injector and detector were set at 250~ and 280~ respectively. The mass spectrometer was operated at 70 eV in the EI mode using selected ion monitoring (SIM) mode. The injection volume was 1 pL in the split mode at a ratio of 10:1. The ions were monitored at m/z 81, 372, and 96 for methylated furosemide ( Figure 2 ) and at m/z 209, 105, and 268 for methylated IS.
Analytical Method

Standard solutions
Stock solutions of furosemide of both lots as well as that of IS were prepared in methanol at 1000 I~g/mL. Subsequently, working solutions for calibration curves and control samples were obtained by serial dilutions with methanol at 100 and 10 pg/mL for furosemide, and at 10 pg/mL for IS. All solutions were protected from light and stored at 4~ until use.
Sample pre-treatment
A 50-pL aliquot of the IS solution (10 pg/mL) was added to 1 mL of human whole blood. The mixture was vortex mixed and sonicated in a sonic bath for 15 min at room temperature. After sonication, 6 mL of phosphate buffer (0.1M, pH 6.0) was added and the mixture was vortex mixed for 30 s before centrifugation at 3000 rpm for 15 rain.
SPE
The extraction of pretreated samples was performed with a Vac-Elut system assembled with BondElut-LRC Certify 300 mg SPE columns. The columns were conditioned with 2 mL methanol and 2 mL of 0.1M phosphate buffer (pH 6.0) before applying the samples, using reduced pressure at low flow speed. The columns were washed successively with I mL of a mixture of phosphate buffer (0.1M, pH 6.0) and methanol (4:1 v/v), 1 mL of acetic acid (1M), and 1 mL ofn-hexane. After each washing step the columns were dried under full vacuum for 5, 10, and 2 min, respectively. The substances of interest were eluted with 4 mL of dichloromethane, and the solvent was subsequently evaporated to dryness in a vacuum rotary evaporator at 40~
Derivatization
The remaining residues were dissolved in 25 pL of TMAH, gently vortex mixed, and directly injected in the GC-EI-MS system in SIM mode. The TMAH reagent was specially formulated for use as a direct on-column methylating agent.
Results
Validation of the analytical method
The proposed strategy included the verification and determination of selectivity, linearity, limits of detection (LOD) and quantitation (LOQ), precision, trueness, and recovery in spiked blood samples. To evaluate the validation parameters, a one-day assay protocol was defined, based on the analysis of the calibration curve with three different concentrations of control samples. Five calibration curves were prepared on different days over several months.
Selectivity
Selectivity was examined by analyzing nine different blank blood samples in order to detect matrix interferences at the retention times and monitored ions. Figure 3 shows the chromatogram from a blank blood sample free of interferences at the retention time of methylated furosemide. Blank blood matrix was analyzed each day. Calibration curves and linearity Calibration curves (peak-area ratio between furosemide and IS versus furosemide concentration) were measured daily, using six levels of spiked blood samples prepared and analyzed in duplicate by the described procedure, between 0.10 and 5.00 I~g/mL. Five replicates of control samples at low, medium, and high concentrations (0.30, 0.75, and 3.001Jg/mL) of furosemide were measured on the same day. The choice of concentration range was based on the therapeutic and toxic range values in serum published in the literature versus what was practically feasible under the applied GC conditions (11) . For concentrations > 51Jg/mL it was decided that the analysis should be repeated after appropriate dilution with blank blood matrix.
Linearity was obtained in the range 0.10-5.00 pg/mL using a series of different levels in duplicate. The selected ions for quantitation were rn/z 81 for methylated furosemide and rn/z 209 for methylated IS. The calibration curve was submitted to linear regression analysis using the least-squares method to obtain the slope and intercept. The correlation coefficient was 0.9941. Because the calculated t-value was greater than the tabulated value the correlation is significant. This linear relationship demonstrated to be statistically significant by using an analysis of variance of the regression (F-test) to compare F values. The F-value obtained is much greater than the F-tabulated, so linearity exists in the studied concentration range. An example of the statistical evaluation of the standard curve is presented in Table I .
LOD and LOQ
LOD and LOQ were calculated based on the standard deviation of the response and the slope of the calibration curve. The following formulas were applied: LOD = (3.3 x SD)/b and LOQ = (10 x SD)/b, where SD was the standard deviation of the response and b the slope of the regression line (22, 23) . The thus calculated and extrapolated LOD and LOQ were 0.010 IJg/mL and 0.0451Jg/mL, respectively.
Trueness and precision
Precision and trueness were estimated at three different concentrations (0.30, 0.75, and 3.00 IJg/mL) with five replicates for each level, analyzed in the same day (intraday precision) and on five different days over five months (interday precision) using one-way ANOVA. Precision was calculated in terms of relative standard deviation (RSD, %), and trueness in terms of relative error (%) between the measured and the spiked concentrations. The obtained values for precision and trueness were less than 15% for all concentration levels (Table II) , falling within the criteria accepted internationally (22, 23) .
Recovery
The relative recovery of the described method was calculated by dividing the amount of the compound measured by the theoretical concentration. Results were 104%, 89%, and 91% for 0.30, 0.75, and 3.00 IJg/mL controls, respectively (Table II) .
Discussion
After several experiments it was verified that the use of sonication and dilution of the blood sample before SPE was of crucial importance because of strong plasma protein binding of furosemide. This way homogenization was more effective, the extracts were cleaner for chromatographic analysis, and the extraction recovery was higher.
In recent years, several studies were published about the determination of furosemide in plasma, serum, and urine in doping control analysis. However, in the field of forensic toxicology, blood samples are the most important matrices for quantitative determinations, and most frequently the only available. The development of a methodology to determine furosemide in authentic blood samples is an important and useful tool, particularly in postmortem toxicology.
Application to an Authentic Sample
The developed experimental protocol was applied to an authentic blood sample obtained from a medicolega] autopsy.
A 48-year-old female with a history of alcohol abuse and suicide attempts was admitted to the hospital after consuming multiple drugs and alcohol. She died 2 h later. At autopsy no evidence of any disease that might have caused death was found, no signs of violence were observed, and intoxication was suspected because of pulmonary edema and general congestion of the inner organs. Histological findings revealed the presence of liver disease in an initial phase. Samples taken for toxicological analysis included tissues, gastric content (including pills), cardiac blood, and femoral blood. The pathologist requested alcohol analysis and a drug screen with specific attention toward furosemide. Ethanol was quantitated in femoral blood using GC-flame-ionization detection with a headspace autosampler. After screening using high-pressure liquid chromatographyphotodiode array detector and GC-EI-MS, disopyramide (an antiarrhythmic) was detected in the blood and in pills recovered from the gastric contents. Furosemide was detected and quantitated using the described methodology. Table III shows the toxicological results.
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Conclusions
The developed procedure showed to be appropriate to determine furosemide in whole blood samples. It offers time reduction in the derivatization step, simplicity, and sensitivity for quantitative determinations of small concentrations of furosemide.
The optimized and validated methodology is suitable for the application in routine analysis in the field of forensic toxicology.
